{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "We therefore wished to compare the outcome of patellofemoral arthroplasty (PFA) with TKA in a blinded randomized controlled trial."
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "One hundred patients were included from 2007 to 2014 and were randomized to PFA or TKA."
      },
      "Participants": {
        "score": 2,
        "evidence": "Patients were eligible if they had debilitating symptoms and isolated patellofemoral disease."
      },
      "Intervention": {
        "score": 2,
        "evidence": "randomized to PFA or TKA."
      },
      "Objective": {
        "score": 1,
        "evidence": "We therefore wished to compare the outcome of patellofemoral arthroplasty (PFA) with TKA in a blinded randomized controlled trial."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "SF-36 bodily pain was the primary outcome."
      },
      "Randomisation_Allocation": {
        "score": 1,
        "evidence": "randomized to PFA or TKA (blinded for the first year; blinded to patient, therapists, primary care physicians, etc; quasiblinded to assessor)."
      },
      "Blinding": {
        "score": 3,
        "evidence": "blinded to patient, therapists, primary care physicians, etc; quasiblinded to assessor."
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "One hundred patients were included from 2007 to 2014 and were randomized to PFA or TKA."
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "Four percent (two of 50) of patients died within the first 2 years in the PFA group (none in the TKA group), and 2% (one of 50) became ill and declined further participation after 1 year in the PFA group (none in the TKA group)."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "The area under the curve (AUC) up to 2 years for SF-36 bodily pain of patients undergoing PFA and those undergoing TKA was 9.2 (SD 4.3) and 6.5 (SD 4.5) months, respectively (p = 0.008)."
      },
      "Harms": {
        "score": 1,
        "evidence": "There was no difference in the number of complications."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 20,
    "max_score": 25
  },
  "model": "gpt-4o"
}